Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy

Steroids

Volumn 75, Issue 1, 2010, Pages 77-82

  Korpi Steiner, Nichole L ^a   Netzel, Brian C ^a   Seegmiller, Jesse C ^a   Hagan, John B ^a   Singh, Ravinder J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Compliance; Inhaler; LC MS MS

Indexed keywords

ACETONITRILE; CARBOXYLIC ACID DERIVATIVE; DICHLOROMETHANE; DRUG METABOLITE; FLUOROMETHOLONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE 17BETA CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG ELIMINATION; DRUG URINE LEVEL; FEMALE; GOLD STANDARD; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION; VALIDATION STUDY;

ADULT; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ASTHMA; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 71849102501     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.10.009     Document Type: Article

References (18)

1. Borish L., and Culp J.A. Asthma: a syndrome composed of heterogeneous diseases. Ann Allergy Asthma Immunol 101 (2008) 1-8 quiz-11, 50
2. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120 (2007) S94-S138
3. Jones K., Berrill W.T., Bromly C.L., and Hendrick D.J. A confidential enquiry into certified asthma deaths in the North of England, 1994-96: influence of co-morbidity and diagnostic inaccuracy. Respir Med 93 (1999) 923-927
4. Bender B.G., Pedan A., and Varasteh L.T. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 118 (2006) 899-904
5. Bender B.G., Bartlett S.J., Rand C.S., Turner C., Wamboldt F.S., and Zhang L. Impact of interview mode on accuracy of child and parent report of adherence with asthma-controller medication. Pediatrics 120 (2007) e471-e477
6. Kaiser H.B. Compliance and noncompliance in asthma. Allergy Asthma Proc 28 (2007) 514-516
7. Callejas S.L., Biddlecombe R.A., Jones A.E., Joyce K.B., Pereira A.I., and Pleasance S. Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 718 (1998) 243-250
8. Bain B.M., Harrison G., Jenkins K.D., Pateman A.J., and Shenoy E.V. A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. J Pharm Biomed Anal 11 (1993) 557-561
9. Brutsche M.H., Brutsche I.C., Munawar M., Langley S.J., Masterson C.M., Daley-Yates P.T., et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 356 (2000) 556-561
10. Harding S.M. The human pharmacology of fluticasone propionate. Respir Med 84 Suppl. A (1990) 25-29
11. Pearce R.E., Leeder J.S., and Kearns G.L. Biotransformation of fluticasone: in vitro characterization. Drug Metab Dispos 34 (2006) 1035-1040
12. Rauh M. Steroid measurement with LC-MS/MS in pediatric endocrinology. Mol Cell Endocrinol 301 (2009) 272-281
13. Kushnir M.M., Rockwood A.L., Roberts W.L., Pattison E.G., Owen W.E., Bunker A.M., et al. Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin Chem 52 (2006) 1559-1567
14. Kushnir M.M., Rockwood A.L., Roberts W.L., Pattison E.G., Bunker A.M., Fitzgerald R.L., et al. Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem 52 (2006) 120-128
15. Xu R.N., Fan L., Rieser M.J., and El-Shourbagy T.A. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharm Biomed Anal 44 (2007) 342-355
16. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 49 (2003) 1041-1044
17. Mackie A.E., Ventresca G.P., Fuller R.W., and Bye A. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. Br J Clin Pharmacol 41 (1996) 539-542
18. Li Y.N., Tattam B.N., Brown K.F., and Seale J.P. A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry. J Pharm Biomed Anal 16 (1997) 447-452